BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29150490)

  • 1. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.
    Gerbes A; Zoulim F; Tilg H; Dufour JF; Bruix J; Paradis V; Salem R; Peck-Radosavljevic M; Galle PR; Greten TF; Nault JC; Avila MA
    Gut; 2018 Feb; 67(2):380-388. PubMed ID: 29150490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW; Chen MS
    Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Hepatocellular carcinoma: A life-threatening disease".
    Chacko S; Samanta S
    Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the management of hepatocellular carcinoma.
    Cabrera R; Nelson DR
    Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatocellular carcinoma.
    Del Pozo AC; López P
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.
    Sacco R; Mirabile A; Giacomelli L; Bresci G; Attardo S; Cabibbo G
    Future Oncol; 2017 Jun; 13(15):1297-1300. PubMed ID: 28589772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation.
    Liapi E; Geschwind JF
    Ann Surg Oncol; 2011 Jun; 18(6):1527-8. PubMed ID: 21431403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multimodality treatment for hepatocellular carcinoma].
    Malek NP; Vogel A; Manns MP
    Internist (Berl); 2010 Nov; 51(11):1374-81. PubMed ID: 20938626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
    Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
    Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional oncology for hepatocellular carcinoma.
    Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.